The Recovery Center, LLC

The Recovery Center, LLC was paid $42.29M by Medicaid between Jan 2018 and Nov 2024, across 22 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 34% of everything it billed.

Compared with peers

Next to other Addiction (Substance Use Disorder) Counselor providers in Kentucky

Rank by total paid#1 of 112

Median peer was paid$240K

This provider vs. median176×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	155,776	$6.58M
2019	161,574	$8.95M
2020	117,758	$7.03M
2021	116,192	$6.12M
2022	86,105	$5.60M
2023	71,771	$5.00M
2024incomplete	42,667	$3.02M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	34%	92,073	71,749	$14.50M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	22%	187,099	88,147	$9.34M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	21%	214,966	94,573	$8.71M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	8.1%	122,745	67,816	$3.44M
T2023	Targeted case management; per month	4.1%	6,738	6,219	$1.73M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.8%	15,737	8,722	$1.20M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.6%	43,807	18,010	$1.09M
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	1.6%	18,381	11,994	$686K
T1007	Alcohol and/or substance abuse services, treatment plan development and/or modification	1.5%	12,159	11,597	$628K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	20,475	10,517	$312K
H0001	Alcohol and/or drug assessment	<1%	3,325	3,200	$186K
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	<1%	2,885	2,624	$178K

10 more codes

90838		<1%	1,290	$90K
90834	Psychotherapy session, about 45 minutes	<1%	2,184	$90K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	4,110	$52K
99203	Doctor's office visit, new patient (routine)	<1%	701	$40K
90836		<1%	225	$12K
36415	Collection of venous blood by venipuncture	<1%	2,876	$4K
99214	Doctor's office visit, returning patient (more involved)	<1%	18	$805.20
99201		<1%	13	$148.30
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	22	$137.16
81025		<1%	14	$8.61

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBURNETTE, GEORGE (OWNER)